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Abstract 
The in vitro fermentation properties of several purified galacto-oligosaccharides (GOS), 
specifically the trisaccharides 4’-galactosyl-lactose and 6’-galactosyl-lactose, and a mixture of 
the disaccharides 6-galactobiose and allolactose, was carried out. The bifidogenic effect of 
GOS at 1% (w/v) was studied in a pH-controlled batch culture fermentation system inoculated 
with healthy adult human faeces. Results were compared with those obtained with a 
commercial GOS mixture (Bimuno-GOS). Changes in bacterial populations measured through 
fluorescence in situ hybridization (FISH) and short-chain fatty acid (SCFA) production were 
determined. Bifidobacteria increased after 10 h fermentation for all the GOS substrates, but the 
changes were only statistically significant (P < 0.05) for the mixture of disaccharides and 
Bimuno-GOS. Acetic acid, whose formation is consistent with bifidobacteria metabolism, was 
the major SCFA synthesized. The acetate concentration at 10 h was similar with all the 
substrates (45-50 mM) and significantly higher than the observed for formic, propionic and 
butyric acids. All the purified GOS could be considered bifidogenic under the assayed 
conditions, displaying a selectivity index (SI) in the range 2.1-3.0, which was slightly lower 
than the determined for the commercial mixture Bimuno-GOS. 
 
Keywords: Batch culture system, Galacto-oligosaccharides, Prebiotics, Transglycosylation, 
β-Galactosidase, FISH, Short-chain fatty acids. 
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Introduction 
Human milk contains a complex mixture of proteins, lipids, enzymes, antibodies, 
nutrients and a variety of nondigestible oligosaccharides that provide an immunological 
protection to infants (Zivkovic et al. 2011). It is well reported that breast-fed infants harbor 
much higher level of bifidobacteria in their faecal microbiota than formula-fed infants due to 
their ability to utilize human milk oligosaccharides (HMOs, Charalampopoulos and Rastall  
2009; Shen et al. 2011). HMOs stimulate the growth of bifidobacteria and lactobacilli, thus 
decreasing the faecal pH and reducing the presence of pathogens (Boehm et al. 2005). In this 
context, the intake of prebiotics such as HMOs influences the composition of the gut 
microbiota by increasing the proportion of these bacteria to other species. This change in 
bacterial populations causes a positive effect on human health as a consequence of immune 
stimulation, inhibition of pathogens, improved absorption of minerals, decrease of serum lipids 
concentration and reduction of cancer risk, among other effects (Gibson 1995; Gibson and 
Rastall 2006; Roberfroid 2007).  
Among the HMOs present in human milk, galacto-oligosaccharides (GOS) constitute a 
major group (Shadid et al. 2007). The total GOS in human milk is approx. 8-12 g/l (Angus et 
al. 2007; Macfarlane et al. 2008) with 3’-, 4’- and 6’-galactosyl-lactose as the main 
components (Boehm  et al. 2005). In the laboratory, GOS can be synthesized with β-
galactosidases (EC 3.2.1.23) by transgalactosylation reactions in which lactose (or the glucose 
and galactose released by hydrolysis) serve as galactosyl acceptors yielding a series of di-, tri- 
and tetrasaccharides and eventually of higher polymerization degree (Park and Oh 2010; Torres 
et al. 2010). The GOS yield is determined by the balance between hydrolysis and 
transgalactosylation reactions (Hsu et al. 2007; Matella et al. 2006). Depending on the 
biological source of β-galactosidase, the yield and composition of GOS vary notably (Iqbal et 
al. 2010; Maischberger et al. 2010; Splechtna et al. 2006; Urrutia et al. 2013). The complete 
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identification of the GOS synthesized by a particular enzyme is a difficult task; in fact, 
considering the formation of β(1→2), β(1→3), β(1→4) and β(1→6) bonds, the number of 
possible linear GOS accounts for 7 disaccharides, 32 trisaccharides, 128 tetrasaccharides and 
so on. It is worth emphasizing that most of the previous in vitro studies to evaluate the 
fermentation selectivity of oligosaccharides have been carried out with complex mixtures 
(Sanz et al. 2005a; Shen  et al. 2011) and only in a few cases with purified products (Cardelle-
Cobas et al. 2011 and 2012). Therefore similar studies with purified individual GOS would be 
of great value to understand the effect of GOS composition and structure on their properties.  
Fermentation selectivity can be estimated using in vitro fermentation systems 
inoculated with human faecal slurries (Sarbini et al. 2011; Shen et al. 2011). The growth of 
bacteria can be measured by fluorescence in situ hybridization (FISH) employing synthetic 
fluorescent oligonucleotide probes that targets specific regions of the 16S rRNA (Langendijk et 
al. 1995). One of the main functions of the microbiota is to salvage energy from nondigested 
carbohydrates in the upper gut. In particular, Bifidobacterium and Lactobacillus species are 
recognized as health-promoting and thus widely used as probiotics (Gomez et al. 2010; 
Mandalari et al. 2007; Vulevic et al. 2004). Concomitant to the increase of bifidobacteria and 
lactobacilli, short-chain fatty acids (SCFA) are produced by oligosaccharide fermentation 
(Charalampopoulos and Rastall 2009) and further absorbed, representing 40-50% of the 
available energy of the carbohydrate. The principal SCFA are acetate, propionate and butyrate, 
which are metabolized by the colonic epithelium (butyrate), liver (propionate) and muscle 
(acetate) (Cummings and Macfarlane 1997). 
The aim of the present study was the initial in vitro evaluation of the potential prebiotic 
properties of several purified galacto-oligosaccharides with different linkages, and the results 
were compared with a commercial GOS mixture.  
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Materials and methods 
Materials 
The commercial β-galactosidases from Bacillus circulans (Biolactase) and Kluyveromyces 
lactis (Lactozym 3000 L HP G) were supplied by Biocon (Spain) and Novozymes A/S 
(Denmark), respectively. All nucleotide probes used for fluorescence in situ hybridization 
(FISH) were commercially synthesized and labelled with the fluorescent dye Cy3 (Sigma-
Aldrich) at the 5´- position. All media and chemicals were purchased from Sigma-Aldrich, 
Oxoid and Fisher Scientific. Sterilization of media and instruments was done by autoclaving at 
121°C for 15 min. The commercial mixture Bimuno-GOS was supplied by Clasado Ltd., with 
52% GOS content. 
 
Purification of GOS  
The 4’-galactosyl-lactose was purified from the reaction mixture obtained with the β-
galactosidase from B. circulans as described by Rodriguez-Colinas et al. (2012). From the 
reaction of lactose with β-galactosidase from K. lactis, 6’-galactosyl-lactose and a mixture of 
allolactose [Gal-β(1→6)-Glc] and 6-galactobiose [Gal-β(1→6)-Gal] were obtained according 
to the protocol described by Rodriguez-Colinas et al. (2011). For the purification of these 
products, the reactions were stopped when yield reached the maximum value for each desired 
oligosaccharide. Products were isolated by semipreparative hydrophilic interaction 
chromatography (HPLC-HILIC) using a quaternary pump (Delta 600, Waters) coupled to a 
LiChrospher-NH2 column (5 µm, 10 x 250 mm, Merck). The column temperature was kept 
constant at 30°C. Acetonitrile/water 90/10 (v/v), degassed with helium, was used as mobile 
phase at 6.25 ml/min for 8 min. Then, a gradient to acetonitrile/water 80/20 (v/v) was 
performed in 3 min, and this eluent was maintained during 6 min. Finally, a gradient to 
acetonitrile/water 75/25 (v/v) was performed in 3 min and maintained for 15 min. Peaks were 
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detected using an evaporative light-scattering detector DDL-31 (Eurosep) equilibrated at 60°C. 
A three-way flow splitter (model Accurate, Dionex) and a fraction collector (Waters) were 
employed. The fractions containing the main peaks were pooled, and the solvent was 
eliminated by rotary evaporation using an ACTEvap evaporation module.  Bimuno-GOS was 
treated with activated charcoal to reduce the content of monosaccharides following the method 
of Morales et al. (2006) with some modifications (Hernandez et al. 2009). Briefly, 500 mg of 
Bimuno-GOS and 3 g of activated charcoal (Darco G60, 100 mesh, Sigma-Aldrich) were 
mixed with 100 ml of ethanol (15% v/v) and stirred for 30 min. The mixture was filtered 
through Whatman No. 1 filters under vacuum and then the activated charcoal was washed with 
the ethanolic solution. Desorption of oligosaccharides from the activated charcoal was carried 
out with 100 ml of ethanol (50% v/v), stirred during 30 min and filtered as previously 
described. The filtrates were evaporated under vacuum at 40-45°C and filtered through 0.20 
µm filters. Water was removed by freeze-drying.  
 
High-performance anion-exchange chromatography with pulsed amperometric detection 
(HPAEC-PAD)  
The analysis of the purity of the isolated GOS was performed by HPAEC-PAD on a ICS3000 
Dionex system (Dionex Corp., Sunnyvale, CA) consisting of a SP gradient pump, an AS-HV 
autosampler and an electrochemical detector with a gold working electrode and Ag/AgCl as 
reference electrode. All eluents were degassed by flushing with helium. A pellicular anion-
exchange 4 x 250 mm Carbo-Pack PA-1 column (Dionex) connected to a CarboPac PA-1 
guard column was used at 30°C. For eluent preparation, MilliQ water and 50% (w/v) NaOH 
(Sigma-Aldrich) were used. The initial mobile phase was 15 mM NaOH at 1.0 ml/min for 12 
min. A mobile phase gradient from 15 mM to 200 mM NaOH was established at 1.0 ml/min 
Applied Microbiology and Biotechnology, Volume 97,  pp 5743-5752 (2013) Digital CSIC 
 
 7 
for 15 min and the latter mobile phase was maintained for 25 min. The peaks were analyzed 
using Chromeleon software version 6.80. Identification of the different carbohydrates was done 
based on commercial GOS standards and other purified and characterized GOS (Rodriguez-
Colinas et al. 2011 and 2012; Urrutia et al. 2013).  
 
Faecal inocula 
Experiments were carried out using fresh faecal samples from four healthy human donors (30 
to 36 years old) who were free of any metabolic and gastrointestinal diseases, were not taking 
probiotic or prebiotic supplements and had not taken antibiotics 6 months before faecal sample 
donation. Samples were diluted 1:10 (w/v) in sterile phosphate-buffered saline (PBS; pH 7.3) 
and homogenized in a stomacher (Stomacher 400, Seward) for 2 min at normal speed. 
 
Batch culture fermentations 
Sterile stirred batch culture fermentation vessels (5 ml working volume) were prepared and 
aseptically filled with 4.5 ml of sterile basal nutrient medium. This medium comprised of 
peptone water (2 g/l), yeast extract (2 g/l), NaCl (0.1 g/l), KH2PO4 (0.04 g/l), MgSO4 x 7 H2O 
(0.01 g/l), CaCl2 x 6 H2O (0.01 g/l), NaHCO3 (2 g/l), Tween 80 (2 ml/l), haemin (0.05 g/l), 
vitamin K (10 µl/l), L-cysteine hydrochloride (0.5 g/l) and bile salts (0.5 g/l). The basal 
medium was adjusted to pH 7.0 and then 4 ml of 0.025% (w/v) resazurin solution was added 
per liter before autoclaving. Once in the fermentation vessels, the sterile medium was sparged 
overnight with O2-free N2 (15 ml/min) to maintain anaerobic conditions. The following day, 
each vessel was inoculated with 0.5 ml of fresh faecal slurry prepared as described before. The 
GOS assayed were added at a concentration of 1% (w/v) to each vessel just prior to the 
addition of the faecal slurry. The temperature of the fermentation vessels was held at 37°C 
using a circulating water bath. The pH was maintained in the range of 6.6-6.9 via pH 
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controllers (Fermac 260, Electrolab) and adjusted by the addition of 0.5 mmol/l NaOH and 
HCl to the vessels when required. Anaerobic conditions were maintained throughout the 
fermentation by sparging the vessels with O2 -free N2 (15 ml/min). Batch culture fermentations 
were ran for 24 h and samples were taken at 0, 5, 10 and 24 h for analysis of bacterial 
populations by FISH and for analysis of SCFA by high-performance liquid chromatography 
(HPLC). Four fermentation experiments were performed, one per faecal donor. 
 
Bacterial populations by FISH 
Synthetic oligonucleotide probes targeting specific regions of the 16S rRNA molecule and 
labelled with a fluorescent dye (Bif164, Lab158, Bac303, Ato291, Chis150, Erec482, Fpra655, 
and Eub 338) were utilized for the enumeration of different bacterial groups (Table 1). FISH 
was performed as described by Martin-Pelaez et al. (2008).  
 
Short-chain fatty acid (SCFA) analysis 
Samples taken from the fermenters were centrifuged (13,000 g for 10 min) and supernatants 
were filtered through 0.22 µm syringe filters (Millex 13 mm filter units, Millipore). Samples 
(20 µl) were injected into an HPLC system equipped with refractive index and UV (210 nm) 
detectors put in series. The ion-exclusion column (Rezex ROA-organic acid, 300 x 7.8 mm, 
Phenomenex) was maintained at 82°C at a flow rate 0.5 ml/min. The eluent used was 2.5 mM 
sulphuric acid in HPLC-grade water. The sample run time was 40 min. SCFA quantification 
was carried out using calibration curve standards for formate, acetate, propionate and butyrate 
at concentrations of 12.5, 25, 50, 75 and 100 mM. 
 
Statistical analysis 
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Differences between bacterial accounts and SCFA profiles at 0, 5, 10 and 24 h fermentation for 
each substrate were tested using SPSS program. Univariate analysis of variance (ANOVA) and 
post-hoc Tukey and Duncan tests were used to determine the significant differences of 
substrates. Differences were deemed significant at P < 0.05. 
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Results  
Production and purification of GOS  
 Several GOS were obtained by transgalactosylation of lactose using two β-
galactosidases (from B. circulans and K. lactis) with different specificity. In the case of K. 
lactis β-galactosidase, the enzyme exhibits a clear tendency to synthesize β-(1→6) bonds: the 
main products are the disaccharides 6-galactobiose [Gal-β(1→6)-Gal] and allolactose [Gal-
β(1→6)-Glc], and the trisaccharide 6’-galactosyl-lactose [Gal-β(1→6)-Gal-β(1→4)-Glc] 
(Martínez-Villaluenga et al. 2008; Rodriguez-Colinas et al. 2011).  In contrast, the B. circulans 
counterpart displays specificity for the formation of β(1→4) bonds; the major product 
synthesized was the trisaccharide 4’-galactosyl-lactose [Gal-β(1→4)-Gal-β(1→4)-Glc] 
(Rodriguez-Colinas et al. 2012). Fig. 1 shows the structures of the GOS assayed in this work. 
The products were purified in 250 mg-scale by semipreparative HPLC. It is noteworthy that the 
two disaccharides (6-galactobiose and allolactose) could not be efficiently separated by this 
technique and were tested as a “disaccharide mixture with β(1→6) bonds” in the fermentation 
assays. 
 The purity of the synthesized GOS was in the range 65-75% as determined by HPAEC-
PAD (Fig. 2). All the samples showed the presence of variable amounts of galactose and 
glucose, as well as other minor oligosaccharides. Table 2 summarizes the different 
carbohydrates employed as substrates in the fermentation studies and their purity. Results were 
compared with a commercial prebiotic GOS (Bimuno-GOS) produced by Bifidobacterium 
bifidum, which was partially purified by activated charcoal to reduce the content of mono- and 
disaccharides. HPAEC-PAD analysis (Fig. 2) shows that Bimuno-GOS contains a complex 
mixture of oligosaccharides. 
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Bacterial enumeration 
Batch pH-controlled fermentations were carried out under anaerobic conditions (Fig. 3) 
in the presence of the GOS synthesized to assess if the chemical structure of these products 
could influence bacterial selectivity. Results were compared with Bimuno-GOS used as a 
reference. Different hybridization probes (Table 1) were employed to count, by fluorescent 
microscopy, numerically dominant and physiologically relevant groups of bacteria. Bacterial 
counts (Table 3) were analyzed statistically for each substrate to determine which variations 
between the different fermentation times (0, 5, 10 and 24 h) could be considered significant.  
As shown in Table 3, no substantial changes were observed in most bacterial 
populations during fermentation with the exception of Faecalibacterium prausnitzii (Fpra655) 
that decreased more than one log10 unit from the 0 h value with P < 0.035. Bifidobacteria 
(Bif164) increased significantly after 10 h fermentation for the mixture of disaccharides (6-
galactobiose and allolactose) with P < 0.01 and for the control (Bimuno-GOS) with P < 0.05, 
whereas a statistically nonsignificant increment was observed for the trisaccharides 4’- and 6’-
galactosyl-lactose. Interestingly, bifidobacterial counts at 24 h remained nearly constant with 
respect to 10 h fermentation. Therefore, all the GOS studied could be considered bifidogenic 
under the assayed conditions. In contrast, only a slight increase of Lactobacillus spp. 
population (P > 0.05) was observed after 10 h fermentation. Bacteroides, which comprises 
about 30% of the total colonic culturable microflora, maintained a stable population throughout 
the fermentation. In addition, purified GOS and Bimuno-GOS did not favour the growth of 
Atopobium spp. and Eubacterium spp. groups. 
 
Short-chain fatty acids (SCFA) analyses 
Table 4 summarizes the concentrations of formate, acetate, propionate and butyrate 
measured by HPLC in the faecal fermentation supernatants with the different substrates and 
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Bimuno-GOS as reference. The chromatographic analyses of SCFA were performed at the 
same time points (0, 5, 10 and 24 h) than the bacterial counts. After 24 h of fermentation, 
acetate was clearly the most prevalent SCFA with all the substrates tested, in agreement with 
the FISH results of bifidobacteria growth. The acetate concentration at 10 h was very similar 
with all the substrates (approx. 45-50 mM). Significant changes in propionate concentration 
throughout fermentation were observed with all the carbohydrates. The highest level (15 mM) 
corresponded to 4’-galactosyl-lactose at 5 h. However, the propionate concentration generally 
decreased after 5 h fermentation.  
Low levels of butyrate were produced upon the fermentation of all the substrates.  This 
can be related with the slight changes in the populations of Clostridium coccoides- 
Eubacterium rectale group, the major butyrate-producing bacterial groups found in human 
faeces (Barcenilla et al. 2000). The tested GOS increased formic acid concentration in the first 
five or ten hours of fermentation with a further decrease until 24 h, except for the mixture of 
disaccharides in which the formate concentration was maintained.  
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Discussion 
The present study was carried out to evaluate the in vitro fermentation properties of 
several purified galacto-oligosaccharides (GOS), namely the trisaccharides 4’-galactosyl-
lactose, 6’-galactosyl-lactose, and a mixture of the disaccharides 6-galactobiose and 
allolactose, which were selectively obtained by a proper selection of the β-galactosidase 
source. 
Methods for the in vitro assessment of prebiotic properties range from the static batch 
cultures to the multiple-stage continuous cultures inoculated with either single/mixed bacterial 
strains or faecal homogenates (Tzortzis and Vulevic 2009). In our work, a batch culture 
fermentation system with a faecal homogenate was analyzed under anaerobic conditions and 
pH control. However, batch and continuous in vitro models do not provide a full picture of the 
complex ecosystem that exists within the large intestine. 
In our study, the GOS assayed gave rise to an increase in Bifidobacterium populations, 
exhibiting certain degree of selectivity for this genus. Rycroft et al. (2001) reported that 
commercial GOS increased the level of bifidobacteria and lactic acid bacteria in human faecal 
batch culture fermentations, in some cases causing clostridia and bacteroides to decline. Sanz 
et al. (2005b) showed that bifidobacterial populations increased with several galactose-
containing disaccharides (e.g. galactobioses, melibiose), whereas a slight increase without 
statistical significance was reported for lactobacilli. In a recent study, Cardelle-Cobas et al. 
(2012) showed that several oligosaccharides derived from lactulose were selectively fermented 
both by Bifidobacterium and lactic acid bacterial populations. The significant decrease of 
Faecalibacterium prausnitzii (Fpra655) that we observed with all substrates in the present 
work was also reported by Sarbini et al. (2011) when studying the fermentation properties of a 
series of linear and α(1→2)-branched dextrans. 
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To determine the global effect of the different GOS on the bacterial populations, the 
selectivity index (SI) was calculated at 10 h fermentation following the formula described by 
Ruiz-Matute et al. (2011): 
 
)/(
)/()/()/()/()/(
010
010010010010010
CountTotalCountTotal
ChisChisBacBacErecErecLacLacBifBifSI −−++=  
 
in which Bif10 and Bif0 are the bifidobacterial counts at 10 h and 0 h, respectively, etc. SI 
values give an idea of the growth of beneficial faecal bacteria (bifidobacteria, 
Lactobacillus/Enterococcus group and Eubacterium rectale group) with respect to the less 
desirable ones (Clostridium histolyticum group and bacteroides). SI values are normalized by 
the total number of bacteria (determined with the Eub probes). 
 Fig. 4 shows that the SI values of the substrates assayed varied in the range 2.1-3.9. The 
highest value was obtained with Bimuno-GOS, which contains a mixture of GOS, thus 
suggesting the possibility of a synergistic effect between the different oligosaccharides or a 
strong effect of β(1→3) linkages present in this sample (Depeint et al. 2008). SI values were 
lower than those reported by Cardelle-Cobas et al. (2012) for lactulose-derived 
oligosaccharides or by Sanz et al. (2005b) for a series of galactobioses. However, SI values 
were similar to those described for honey oligosaccharides (Sanz et al. 2005a) or cellobiose-
derived oligosaccharides (Ruiz-Matute et al. 2011). However, comparison of SI values must be 
performed with caution because significant differences can be encountered between the human 
donors (Cardelle-Cobas et al. 2012). 
 SCFA are produced as the end of oligosaccharide fermentation (Wang and Gibson 
1993), and present positive implications in the prevention of colon cancer (Cummings 1981). 
The fermentation of all GOS substrates induced the production of acetate, which correlated 
with the increase of Bifidobacterium populations, as acetate formation is consistent with 
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bifidobacteria and lactobacilli metabolism (Macfarlane et al. 2008). The propionate production 
in all fermentations studied could be related with the slight −although statistically 
nonsignificant− increase of Chys150 group, because several species within the Clostridium 
histolyticum group are able to produce propionate (Sarbini et al. 2012). The low concentration 
of butyrate could be related with the decrease of Faecalibacterium prausnitzii (Fpra655) 
populations determined by FISH. 
In conclusion, the above results indicate that the GOS tested, which present different 
polymerization degree, composition and/or glycosidic linkages, display a similar in vitro 
fermentation selectivity towards the Bifidobacterium genus, which does not substantially differ 
from that observed with the GOS mixture Bimuno-GOS. The GOS assayed also promoted the 
decrease of Faecalibacterium prausnitzii group. The SCFA production correlated well with 
changes in bacterial populations; acetate was the most prevalent fatty acid formed. 
Interestingly, disaccharides containing β(1→6) linkages presented similar bifidogenic 
properties than the trisaccharides containing β(1→4) and β(1→6) bonds.  
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Table 1. Probes used for FISH analysis of bacterial populations in samples from batch culture systems. 
Probe  Specifity 
Temperature (°C) 
Sequence (5´ to 3´) Reference 
Hybridization Washing 
Bif164 Bifidobacterium spp. 50 50 CATCCGGCATTACCACCC Langendijk  et al. 1995 
Lab158 Lactobacillus-Enterococcus 50 50 GGTATTAGCAYCTGTTTCCA Harmsen et al. 1999 
Bac303 
Most Bacteroidaceae and 
Prevotellaceae, some 
Porphyromonadaceae 
46 48 CCAATGTGGGGGACCTT Manz et al. 1996 
Ato291 Atopobium cluster 50 50 GGTCGGTCTCTAACCC Harmsen et al. 2000 
Chis150 
Most of Clostridium 
histolyticum group 
(Clostridium cluster I and II) 
50 50 TTATGCGGTATTAATCTYCCTTT Franks et al. 1998 
Erec482 
Most of Clostridium 
coccoides-Eubacterium 
rectale group  
50 50 GCTTCTTAGTCARGTACCG Franks  et al. 1998 
Fpra655 
Faecalibacterium prausnitzii 
and relatives 
58 58 CGCCTACCTCTGCACTAC Hold et al. 2003 
Eub 338a 
Eubacterium spp. 46 48 
GCTGCCTCCCGTAGGAGT 
Daims et al. 1999 Eub 338IIa GCAGCCACCCGTAGGTGT 
Eub 338IIIa GCTGCCACCCGTAGGTGT 
a
 These probes are used together in equimolar concentration (all at 50 ng/µl)
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Table 2.  Substrates employed in this study to investigate the fermentation selectivity. 
 
Degree of 
polymerization 
Substrate  Structure Enzyme source 
HPAEC-PAD purity 
(%) 
Trisaccharide 4’-Galactosyl-lactose Gal-β(1→4)-Gal-β(1→4)-Glc B. circulans 65 
Trisaccharide 6’-Galactosyl-lactose Gal-β(1→6)-Gal-β(1→4)-Glc K. lactis 71 
Disaccharides 
Allolactose  
6-Galactobiose  
Gal-β(1→6)-Glc  
Gal-β(1→6)-Gal 
K. lactis 76 
Mixture Bimuno-GOS Contains mainly β(1→3) linkages a B. bifidum - 
a
 Depeint et al. 2008
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Table 3. Mean bacterial populations in pH-controlled batch cultures at 0, 5, 10 and 24 h. The starting concentration of the test substrates was 1% 
(w/v) of 5 ml batch culture fluid. Experiments were carried out using fresh faecal samples from four healthy human donors. 
a Standard deviations are shown in parenthesis  
†  Significant difference from the 0 h value for the same substrate with P < 0.05;  ‡  Significant difference from the 5 h value for the same substrate with P < 0.05 ; In bold type: significant differences with P < 0.01. 
Probe/stain Time point (h) 
Bacterial population (log 10 cells/ml batch culture fluid)
a
 
Allolactose + 6-Galactobiose 4’-Galactosyl-lactose 6’-Galactosyl-lactose Bimuno-GOS 
Bif 164 
0  8.97 (0.33)    8.97 (0.33) 8.97 (0.33)      8.97 (0.33) 
5  8.62 (0.14)  8.67 (0.45)   8.57 (0.16)       8.57 (0.17)  
10  9.24 (0.10) ‡  9.19 (0.32)   8.97 (0.46)       9.17 (0.21) ‡ 
24 9.22 (0.20) ‡ 9.10 (0.17)   9.04 (0.27)       9.24 (0.11) ‡ 
Lab158 
0 7.81 (0.01)  7.81 (0.01) 7.81 (0.01)      7.81 (0.01) 
5  8.26 (0.37)   8.10 (0.45)   8.00 (0.64)        8.06 (0.51)  
10  8.00 (0.66)   8.00 (0.45)   8.05 (0.59)        8.14 (0.39) 
24  7.88 (0.66)   8.04 (0.49)   8.10 (0.53)       7.99 (0.59)  
Bac303 
0  9.09 (0.19)     9.09 (0.19)     9.08 (0.19)       9.09 (0.19) 
5       8.60 (0.25) †     8.73 (0.22) †  8.68 (0.19)       8.66 (0.27) 
10  8.88 (0.11)   8.97 (0.10)  9.06 (0.08)        9.00 (0.33) 
24  9.03 (0.08) ‡  9.25 (0.12) ‡   9.20 (0.31) ‡       9.03 (0.25) 
Ato291 
0  8.78 (0.12)  8.78 (0.12)  8.78 (0.12)       8.78 (0.12) 
5  8.42 (0.29)      8.39 (0.10) †  8.33 (0.60)       8.34 (0.30) 
10  8.53 (0.16)   8.76 (0.34) ‡  8.46 (0.34)      8.62 (0.25) 
24   8.61 (0.19)  8.80 (0.27) ‡  8.65 (0.27)       8.69 (0.21)  
Chis150 
0  8.58 (0.15)  8.58 (0.15)  8.58 (0.15)      8.58 (0.15) 
5  8.79 (0.60)   8.91 (0.43)   8.92 (0.35)      8.80 (0.42) 
10  8.88 (0.38)   8.84 (0.47)   8.40 (0.51)       8.68 (0.61)  
24  9.14 (0.08)   8.79 (0.56)   8.97 (0.35)       8.66 (0.59)  
Erec482 
0 9.39 (0.05)  9.39 (0.05) 9.39 (0.05)      9.39 (0.05) 
5      9.09 (0.08) †  9.04 (0.21)  8.67 (0.81)      9.08 (0.15)  
10 9.25 (0.13)  9.07 (0.27)  9.15 (0.21)      9.23 (0.12)  
24 9.22 (0.13)   9.08 (0.70) 9.05 (0.14)      9.09 (0.30)  
Fpra655 
0 8.87 (0.20)  8.87 (0.20) 8.87 (0.20)      8.87 (0.20) 
5      7.84 (0.08) †  7.91 (0.12)      7.78 (0.22) †          7.90 (0.13) † 
10      7.17 (0.06) † , ‡    7.74 (0.56) †      7.31 (0.16) †          7.32 (0.50) † 
24      7.06 (0.40) † , ‡     7.28 (0.80) †       7.04 (0.62) †         7.30 (0.44) † 
Eub338 
0 9.68 (0.17) 9.68 (0.17)   9.68 (0.17)    9.68 (0.17) 
5    9.34 (0.19) †  9.38 (0.13)     9.29 (0.32)      9.45 (0.06)  
10 9.49 (0.12)  9.40 (0.23)     9.44 (0.08)     9.46 (0.20) 
24 9.54 (0.13)   9.67 (0.12)     9.51 (0.21)      9.69 (0.25)  
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Table 4. Short-chain fatty acid (SCFA) concentrations in pH-controlled batch cultures at 0, 5, 10 and 24 h. Mean values were calculated from 
experiments carried out using fresh faecal samples from four healthy human donors. 
 
a
  Standard deviations are shown in parenthesis  
†  Significant difference from the 0 h value for the same substrate with P < 0.05   
‡  Significant difference from the 5 h value for the same substrate with P < 0.05  
§  Significant difference from the 10 h value for the same substrate with P < 0.05  
In bold type: significant differences with P < 0.01. 
 
SCFA Time point (h) 
Mean SCFA concentrations (mM)a 
Allolactose + 6-Galactobiose 4’-Galactosyl-lactose 6’-Galactosyl-lactose Bimuno-GOS 
Formate 
0    0.00 (0.00)   0.00 (0.00)    0.00 (0.00) 0.00 (0.00) 
5      9.41 (2.61)†      5.10 (1.07) †       8.74 (3.42)  †    6.87 (1.20) † 
10     10.2 (3.6) †        14.3 (0.7) †, ‡      11.4 (4.1) †     4.91 (1.49)  † 
24      9.31 (2.62) †          0.00 (0.00) ‡, §       1.43 (0.95) §        3.57 (0.04) †, ‡ 
Acetate 
0 0.40 (0.11) 0.40 (0.11) 0.40 (0.11) 0.40 (0.11) 
5 22.6 (3.4)   19.0 (3.0) †    22.0 (4.2) † 21.9 (4.0) 
10        49.8 (5.6)  †, ‡       45.2 (0.2) †, ‡        49.7 (6.9) †, ‡     49.6 (12.1) †, ‡ 
24             78.7 (17.9) †, ‡, §           60.0 (6.2) †, ‡, §    18.2 (0.4) †, §          99.9 (4.8)  †, ‡, § 
Propionate 
0 0.18 (0.05) 0.18 (0.05) 0.18 (0.05) 0.18 (0.05) 
5  3.13 (0.06) †   15.0 (1.6) †    5.06 (0.23) †    7.85 (1.33) † 
10  3.08 (0.61) †     3.71 (0.82) ‡    3.03 (0.58) †, ‡    1.42 (0.19) ‡ 
24    4.84 (1.33) †    5.89 (3.18) ‡        3.93 (0.76) †        9.52 (0.14) †, § 
Butyrate 
0 0.32 (0.02) 0.32 (0.02) 0.32 (0.02) 0.32 (0.02) 
5 3.06 (0.15) † 2.76 (0.47) † 2.04 (0.92) 3.45 (0.66) 
10 1.94 (0.47) † 2.05 (0.40) 1.68 (0.91) 2.75 (0.83) 
24 3.78 (0.42) †, § 4.62 (1.13) †, § 3.34 (1.65) 8.51 (2.12) † 
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 Figure Legends 
 
Fig. 1. Structure of the GOS assayed in this study: (A) 4’-Galactosyl-lactose; (B) 6’-
Galactosyl-lactose; (C.1) Allolactose; (C.2) 6-Galactobiose. 
 
Fig. 2. HPAEC-PAD analysis of the GOS assayed: (A) 4’-Galactosyl-lactose; (B) 6’-
Galactosyl-lactose; (C) Mixture of allolactose and 6-galactobiose; (D) Bimuno-GOS after 
treatment. Peaks: (1) Galactose; (2) Glucose; (3) 6-Galactobiose ; (4) Allolactose; (5) Lactose; 
(6) 6’-Galactosyl-lactose; (7) 4’-Galactosyl-lactose; (8) Gal-β(1→4)-Gal-β(1→3)-Glc; (9) Gal-
β(1→4)-Gal-β(1→4)-Gal-β(1→4)-Glc. 
 
Fig. 3. Scheme of the fermentation vessels employed in the pH-controlled faecal batch 
cultures: (1) Gas outlet; (2) N2 inlet; (3) pH electrode; (4) Base feeder; (5) Acid feeder; (6) 
H2O inlet at 37°C; (7) H2O outlet. 
 
Fig. 4.  Selectivity index (SI) scores of the different GOS determined from pH-controlled batch 
culture fermentations (10 h).  
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